Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission

A. David Paltiel, Amy Zheng, Paul E. Sax
doi: https://doi.org/10.1101/2021.02.06.21251270

Article Information

doi 
https://doi.org/10.1101/2021.02.06.21251270
History 
  • February 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. A. David Paltiel, PhD1,*,
  2. Amy Zheng, BA3 and
  3. Paul E. Sax, MD2,3
  1. 1Public Health Modeling Unit, Yale School of Public Health, New Haven, CT
  2. 2Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA
  3. 3Harvard Medical School, Boston, MA
  1. ↵*Corresponding Author
    : A. David Paltiel, PhD, Yale School of Public Health, 60 College Street, New Haven CT 06510 (203) 436-4081, david.paltiel{at}yale.edu
Back to top
Posted February 08, 2021.
Download PDF
Data/Code
Email
Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission
A. David Paltiel, Amy Zheng, Paul E. Sax
medRxiv 2021.02.06.21251270; doi: https://doi.org/10.1101/2021.02.06.21251270
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area